NCT02362516View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Healthy
Interventions
DRUG

BI 425809

Trial Locations (1)

Unknown

1346.3.32001 Boehringer Ingelheim Investigational Site, Antwerp

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02362516 - Pharmacokinetics and Pharmacodynamic Effect of Different Multiple Oral Doses of BI 425809 | Biotech Hunter | Biotech Hunter